ALLIANCE A221602

Primary Category:

Cancer Control and Prevention Protocols

Disease Category:

Other

Status:

Closed

Olanzapine With or Without Fosaprepitant for the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV)in Patients Receiving Highly Emetogenic Chemotherapy (HEC): A Phase III Randomized, Double Blind, Placebo-Controlled Trial

NCT#03578081

Eligible for screening study DCP 001

A221602 is permanently closed to accrual, effective July 26, 2021.